Levofloxacin-Induced Eosinophilic Pneumonia with Systemic Manifestations: A Case Report and Literature Review
Keigo Tokunaga1, Masaru Murasawa1, Chisato Yamamura1
1Department of Nephrology, Gyotoku General Hospital, Japan.
Abstract:
Drug-induced eosinophilic pneumonia (D-EP) is a rare adverse drug reaction that can rapidly progress to life-threatening respiratory failure without the timely withdrawal of the offending agent. We herein present the case of a 73-year-old man who developed diffuse erythema, dyspnea, and renal impairment 22 days after the initiation of levofloxacin. Laboratory evaluation revealed marked eosinophilia, and chest CT revealed diffuse ground-glass opacities. His respiratory status deteriorated, thus necessitating noninvasive positive pressure ventilation. Discontinuation of levofloxacin and prompt corticosteroid therapy led to the resolution of the skin lesions, an improvement of the renal function, and recovery, thereby allowing for successful discharge.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Data Reporting and Recording
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:


